Cargando…
Recombinant Poxvirus and the Tumor Microenvironment: Oncolysis, Immune Regulation and Immunization
Oncolytic viruses (OVs) are being extensively studied for their potential roles in the development of cancer therapy regimens. In addition to their direct lytic effects, OVs can initiate and drive systemic antitumor immunity indirectly via release of tumor antigen, as well as by encoding and deliver...
Autores principales: | Sharp, Daniel W., Lattime, Edmund C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298125/ https://www.ncbi.nlm.nih.gov/pubmed/28191451 http://dx.doi.org/10.3390/biomedicines4030019 |
Ejemplares similares
-
Poxvirus Recombination
por: Evans, David Hugh
Publicado: (2022) -
The Addition of Recombinant Vaccinia HER2/neu to Oncolytic Vaccinia-GMCSF Given into the Tumor Microenvironment Overcomes MDSC-Mediated Immune Escape and Systemic Anergy
por: de Vries, Christiaan R., et al.
Publicado: (2015) -
Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment
por: Wang, Lihong, et al.
Publicado: (2022) -
Poxviruses and the immune system: Implications for monkeypox virus
por: Saghazadeh, Amene, et al.
Publicado: (2022) -
Current understanding of reovirus oncolysis mechanisms
por: Phillips, Matthew B, et al.
Publicado: (2018)